KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: A case-control study

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Pan, Ning ^a,b   Jiang, Wei ^a,b   Sun, Hang ^a,b   Miao, Fengqin ^a,b   Qiu, Jie ^b,c   Jin, Hui ^b   Xu, Jinhuan ^a,b   Shi, Qian ^a,b   Xie, Wei ^a,b   Zhang, Jianqiong ^a,b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Nanjing Second Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEPATITIS B; HUMAN; HUMAN LEUKOCYTE ANTIGEN A GENE; HUMAN LEUKOCYTE ANTIGEN B GENE; HUMAN LEUKOCYTE ANTIGEN C GENE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR GENE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; TUMOR GENE; DISEASE COURSE; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; VIROLOGY;

HEPATITIS B VIRUS; MUS MUSCULUS;

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, KIR;

EID: 80053592374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025682     Document Type: Article

References (44)

1. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
2. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
3. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, et al. (2009) Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 1155: 206-221.
4. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, et al. (2007) Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204: 667-680.
5. Chen Y, Sun R, Jiang W, Wei H, Tian Z, (2007) Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner. J Hepatol 47: 183-190.
6. Kakimi K, Lane TE, Wieland S, Asensio VC, Campbell IL, et al. (2001) Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194: 1755-1766.
7. Chen Y, Wei H, Sun R, Dong Z, Zhang J, et al. (2007) Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46: 706-715.
8. Lanier LL, (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
9. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B, (2008) Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118: 1017-1026.
10. Middleton D, Gonzalez A, Gilmore PM, (2007) Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum Immunol 68: 128-134.
11. Maxwell LD, Wallace A, Middleton D, Curran MD, (2002) A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60: 254-258.
12. Gumperz JE, Barber LD, Valiante NM, Percival L, Phillips JH, et al. (1997) Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 158: 5237-5241.
13. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P, (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181: 1133-1144.
14. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M, (1994) NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180: 1235-1242.
15. Kulkarni S, Martin MP, Carrington M, (2008) The Yin and Yang of HLA and KIR in human disease. Semin Immunol 20: 343-352.
16. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N, (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161: 571-577.
17. Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A 105: 3053-3058.
18. Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, et al. (2010) HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J Immunol 184: 2057-2064.
19. Parsons MS, Zipperlen K, Gallant M, Grant M, (2010) Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells. J Leukoc Biol 88: 905-912.
20. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, et al. (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201: 1069-1075.
21. Butsch Kovacic M, Martin M, Gao X, Fuksenko T, Chen CJ, et al. (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14: 2673-2677.
22. Lopez-Vazquez A, Rodrigo L, Martinez-Borra J, Perez R, Rodriguez M, et al. (2005) Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 192: 162-165.
23. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, et al. (2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169: 5118-5129.
24. Dunn PP, Cox ST, Little AM, (2003) Sequencing protocols for detection of HLA class I polymorphism. Methods Mol Biol 210: 191-222.
25. Helmberg W, Dunivin R, Feolo M, (2004) The sequencing-based typing tool of dbMHC: typing highly polymorphic gene sequences. Nucleic Acids Res 32: W173-175.
26. Jiang W, Zhang JQ, Pan N, Xu JH, Xie W, (2008) Identification of a novel HLA-A allele, HLA-A*9216. Tissue Antigens 71: 479-480.
27. Miao F, Sun H, Pan N, Shen Y, Xie W, et al. Identification of a novel HLA class I allele, HLA-Cw*0134 in a Chinese individual. Tissue Antigens 75: 737-738.
28. Stern M, Ruggeri L, Capanni M, Mancusi A, Velardi A, (2008) Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood 112: 708-710.
29. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, et al. (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34: 1673-1679.
30. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
31. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
32. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
33. Brodin P, Karre K, Hoglund P, (2009) NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 30: 143-149.
34. Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, et al. (2004) MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 173: 1819-1825.
35. Kafrouni MI, Brown GR, Thiele DL, (2001) Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms. J Immunol 167: 1566-1574.
36. Shamliyan TA, MacDonald R, Shaukat A, Taylor BC, Yuan JM, et al. (2009) Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med 150: 111-124.
37. Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, et al. (2007) Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 46: 395-401.
38. Rani M, Yang B, Nesbit R, (2009) Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications. Bull World Health Organ 87: 707-713.
39. Yao GB, (1996) Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 38 (Suppl 2): S39-42.
40. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42: 755-758.
41. Yin XL, Guo KY, Ma HJ, Shang ZC, Xiao LL, et al. (2004) [Killer immunoglobulin-like receptor gene distribution in Guangdong Han population]. Di Yi Jun Yi Da Xue Xue Bao 24: 1416-1418.
42. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, et al. (2004) Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53: 1494-1498.
43. Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, et al. (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195: 5-11.
44. Carr WH, Pando MJ, Parham P, (2005) KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175: 5222-5229.